BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1532491)

  • 41. Binding of plasminogen to Neisseria meningitidis and Neisseria gonorrhoeae and formation of surface-associated plasmin.
    Ullberg M; Kuusela P; Kristiansen BE; Kronvall G
    J Infect Dis; 1992 Dec; 166(6):1329-34. PubMed ID: 1385549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of plasminogen activation by polymerized ampicillin.
    al-Roof Higazi A; Hermoni M; Aziza R; Mayer M
    Thromb Res; 1994 Sep; 75(6):643-51. PubMed ID: 7831683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kinetic study of the effect of heparin on the amidase activity of trypsin, plasmin and urokinase.
    Yomtova VM; Stambolieva NA; Blagoev BM
    Thromb Haemost; 1983 Jun; 49(3):199-203. PubMed ID: 6224310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Modified ELISA Method to Evaluate the Interaction of Schistosoma mansoni Proteins with Plasminogen.
    Fernandes LGV; Fernandes RS; Nascimento ALTO; Leite LCC
    Methods Mol Biol; 2020; 2151():185-195. PubMed ID: 32452005
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unesterified long chain fatty acids inhibit the binding of single chain urokinase to the urokinase receptor.
    al-Roof Higazi A; Aceto JF; Kniss D; Upson R; Cohen R; Dichek DA; Cines DB
    Biochemistry; 1996 May; 35(21):6884-90. PubMed ID: 8639640
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Receptor for plasmin on human carcinoma cells.
    Burtin P; Fondaneche MC
    J Natl Cancer Inst; 1988 Jul; 80(10):762-5. PubMed ID: 2838642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modulation of plasminogen activation and plasmin activity by methylglyoxal modification of the zymogen.
    Léránt I; Kolev K; Gombás J; Machovich R
    Biochim Biophys Acta; 2000 Jul; 1480(1-2):311-20. PubMed ID: 10899632
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of plasmin, plasminogen activators and a plasmin inhibitor on bovine in vitro embryo production.
    Papanikolaou T; Amiridis GS; Dimitriadis I; Vainas E; Rekkas CA
    Reprod Fertil Dev; 2008; 20(2):320-7. PubMed ID: 18255022
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kinetic studies of the urokinase catalysed conversion of NH2-terminal lysine plasminogen to plasmin.
    Christensen U; Müllertz S
    Biochim Biophys Acta; 1977 Jan; 480(1):275-81. PubMed ID: 137749
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of Pseudomonas fluorescens M3/6 bacterial protease on plasmin system and plasminogen activation.
    Frohbieter KA; Ismail B; Nielsen SS; Hayes KD
    J Dairy Sci; 2005 Oct; 88(10):3392-401. PubMed ID: 16162512
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of the interaction of human plasmin with its specific receptor on a group A streptococcus.
    Broeseker TA; Boyle MD; Lottenberg R
    Microb Pathog; 1988 Jul; 5(1):19-27. PubMed ID: 2977421
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Binding and activation of plasminogen at the surface of human keratinocytes.
    Reinartz J; Batrla R; Boukamp P; Fusenig N; Kramer MD
    Exp Cell Res; 1993 Sep; 208(1):197-208. PubMed ID: 8359216
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasminogen acquisition and activation at the surface of leptospira species lead to fibronectin degradation.
    Vieira ML; Vasconcellos SA; Gonçales AP; de Morais ZM; Nascimento AL
    Infect Immun; 2009 Sep; 77(9):4092-101. PubMed ID: 19581392
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
    Suenson E; Thorsen S
    Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A spectrophotometric assay for the determination of the catalytic efficiency of plasminogen activators using a slowly hydrolyzed plasmin substrate.
    Castro MJ; Kingston IB; Anderson S
    Anal Biochem; 1995 Apr; 226(2):225-31. PubMed ID: 7793622
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Allosteric effects of some antifibrinolytic amino acids on the catalytic activity of human plasmin.
    Christensen U
    Biochim Biophys Acta; 1978 Sep; 526(1):194-201. PubMed ID: 150862
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Conversion of Glu-plasminogen to plasmin by urokinase in the presence of tranexamic acid.
    Takada A; Takada Y
    Thromb Res; 1981 May; 22(4):437-43. PubMed ID: 6457415
    [No Abstract]   [Full Text] [Related]  

  • 58. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
    Wu JH; Diamond SL
    Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The autodigestion of human plasmin follows a bimolecular mode of reaction subject to product inhibition.
    Jespersen J; Gram J; Astrup T
    Thromb Res; 1986 Feb; 41(3):395-404. PubMed ID: 2939586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mycoplasma cells stimulate in vitro activation of plasminogen by purified tissue-type plasminogen activator.
    Tarshis M; Morag B; Mayer M
    FEMS Microbiol Lett; 1993 Jan; 106(2):201-4. PubMed ID: 8454185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.